Gene expression profiling with DNA microarrays: Advancing our understanding of psychiatric disorders

被引:91
作者
Pongrac, J
Middleton, FA
Lewis, DA
Levitt, P
Mirnics, K
机构
[1] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Sch Med, Dept Neurosci, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Sch Med, Dept PittArray Core, Pittsburgh, PA 15261 USA
[5] Vanderbilt Univ, John F Kennedy Ctr Human Dev, Nashville, TN 37203 USA
[6] Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA
关键词
gene; expression; profiling; microarray; human; psychiatric;
D O I
10.1023/A:1020904821237
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA microarray transcriptome profiling of the postmortem brain opens novel horizons in understanding molecular changes associated with complex psychiatric disorders. With careful analysis and interpretation of microarray data we are uncovering previously unknown, expression patterns that maybe subject-specific and pivotal in understanding the disease process. In our recent studies, analyses of the prefrontal cortex of subjects with schizophrenia and matched controls uncovered complex changes in the expression of genes related to presynaptic secretory release, GABAergic and glutamatergic transmission, metabolic pathways, myelination, as well as cAMP and phosphoinositol second messenger systems. Our goal will be to integrate this expression data within the context of the relevant anatomical, biochemical, molecular, imaging and clinical findings.
引用
收藏
页码:1049 / 1063
页数:15
相关论文
共 138 条
[41]   Sharing gene expression data: an array of options [J].
Geschwind, DH .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (06) :435-438
[42]  
Geschwind DH, 1998, DEV GENET, V23, P215, DOI 10.1002/(SICI)1520-6408(1998)23:3<215::AID-DVG7>3.0.CO
[43]  
2-X
[44]  
Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.3.CO
[45]  
2-5
[46]  
Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.3.CO
[47]  
2-1
[48]   Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents [J].
Glick, ID ;
Lemmens, P ;
Vester-Blokland, E .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (05) :265-274
[49]  
Gold SJ, 1997, J NEUROSCI, V17, P8024
[50]   Cognitive functioning in schizophrenia - Effects of drug treatments [J].
Green, JF ;
King, DJ .
CNS DRUGS, 1996, 6 (05) :382-398